Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

ProPhase Labs, Inc. (PRPH)

$0.06 +1.03% OTC: PRPH · 15-min delayed
  • NEW YORK, New York
  • Public · OTC: PRPH
$4.3MRevenue · FY2025
-$14.7MNet income
PRPHOTC

About ProPhase Labs, Inc.

PROPHASE LABS INC

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$4.3M
Net income
-$14.7M
Total assets
$59.9M
Gross margin
31.9%
Operating margin
-415.4%
Net margin
-339.3%

Source: SEC EDGAR · updated Jun 8, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$4.3M
Cost of revenue
$3.0M
Gross profit
$1.4M
Operating expenses
$19.4M
Operating income
-$18.0M
Income tax
$0
Net income
-$14.7M
EPS (basic)
$-1.74
EPS (diluted)
$-1.74

Balance sheet

Total assets
$59.9M
Current assets
$3.1M
Total liabilities
$56.4M
Current liabilities
$53.1M
Shareholders’ equity
$3.5M

Cash flow

Operating cash flow
-$8.3M
Investing cash flow
$920.0K
Financing cash flow
$6.8M
Net cash flow
-$588.0K

Statements via Polygon.io (SEC filings)

OTC: PRPH
$0.06 +1.03%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.06 $6.08

52-week range

EPS (diluted)
$-1.74
Open
Day range
Prev close
Volume

ProPhase Labs, Inc. (PRPH) Stock Price

  • Reported a net loss of $14.7M in FY2025.
  • Revenue declined 95% from FY2021 to FY2025.
  • Gross margin of 31.9%, net margin -339.3%.
  • Trading 99% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review ProPhase Labs, Inc..

Write a review
Newsroom

News about ProPhase Labs, Inc.

News & sentiment via Polygon.io

FAQ

ProPhase Labs, Inc.: frequently asked questions

Is ProPhase Labs, Inc. an American company?

ProPhase Labs, Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is ProPhase Labs, Inc. headquartered?

ProPhase Labs, Inc. is headquartered in New York, New York, United States.

Is ProPhase Labs, Inc. publicly traded?

Yes — ProPhase Labs, Inc. is a publicly traded company. Its stock trades under the ticker symbol PRPH on the OTC.

What does ProPhase Labs, Inc. do?

ProPhase Labs, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore

Similar companies

Browse all →